APTV vs LCTX · P/E 41, rev $19.71B vs rev $9.5M
Aptiv PLC (APTV) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the APTV and LCTX stock pages for the full models.
Not investment advice.